TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.1720
-0.0136 (-7.33%)
Nov 12, 2026, 1:45 PM EST - Market open
TCRX's stock price has decreased by -82.97% in the past year and price targets may not have had time to catch up.
TScan Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $7 → $1 | Hold | Downgrades | $7 → $1 | +481.40% | Sep 8, 2026 |
| LifeSci Capital | LifeSci Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Sep 2, 2026 |
| Needham | Needham | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Sep 2, 2026 |
| Wedbush | Wedbush | Hold Downgrades $5 → $1 | Hold | Downgrades | $5 → $1 | +481.40% | Sep 2, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 17, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 13, 2026 |